PDCD1 and glioblastoma: The results revealed that compared to the control group, both the GBM + EMF group and the GBM + anti-PD-1 group exhibited a significant reduction in tumor volume and weight (Fig. 4G, P < 0.01), along with a significant increase in the number of apoptotic cells in tumor tissues (Fig. 4H, P < 0.01).